Evidence map›Paper›PMID 24902122›Full record

ArticlemBio2014

The Haemophilus ducreyi LspA1 protein inhibits phagocytosis by using a new mechanism involving activation of C-terminal Src kinase.

Dana A Dodd, Randall G Worth, Michael K Rosen, Sergio Grinstein, Nicolai S C van Oers, Eric J Hansen

Open access · goldAbstract read
In one paragraph

Article in mBio, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Molecular pathogenesis ofMicrobiology and molecular biology reviews : MMBR · 2025
    Review
  3. Article
  4. Review
  5. Apoptosis regulation by the tyrosine-protein kinase CSK.Frontiers in cell and developmental biology · 2022
    Review
  6. Article
  7. Interactions of the Skin PathogenFrontiers in immunology · 2020
    Review
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Dana A DoddDepartment of Microbiology, The University of Texas Southwestern Medical School, Dallas, Texas, USA.
Randall G WorthDepartment of Medical Microbiology and Immunology, University of Toledo College of Medicine and Life Sciences, Toledo, Ohio, USA.
Michael K Rosen
Sergio GrinsteinCell Biology Program, Hospital for Sick Children, Toronto, Ontario, Canada.
Nicolai S C van Oers
Eric J HansenDepartment of Microbiology, The University of Texas Southwestern Medical School, Dallas, Texas, USA Eric.Hansen@UTSouthwestern.edu.
The University of Texas Southwestern Medical Center · USUniversity of Toledo · USHospital for Sick Children · CA

Funding

STRUCTURAL STUDY OF RHO-GTPASE REGULATORS AND EFFECTORSR01GM056322 · NIGMS · UT SOUTHWESTERN MEDICAL CENTER · PI ROSEN, MICHAEL K · 1997 to 2019
$5.7M
Haemophilus ducreyi Inhibits PhagocytosisR37AI032011 · NIAID · UT SOUTHWESTERN MEDICAL CENTER · PI HANSEN, ERIC JOHN · 2006 to 2015
$3.8M
MOLECULAR PATHOGENESIS OF CHANCROIDR01AI032011 · NIAID · UNIVERSITY OF TEXAS SW MED CTR/DALLAS · PI HANSEN, ERIC JOHN · 1992 to 2004
$1.7M
Haemophilus ducreyi Inhibits PhagocytosisR56AI032011 · NIAID · UNIVERSITY OF TEXAS SW MED CTR/DALLAS · PI HANSEN, ERIC JOHN · 2005 to 2005
$390k
CIHR MOP7075CIHR MOP93634NIAID NIH HHS AI32011NIAID NIH HHS R01 AI032011NIAID NIH HHS R37 AI032011NIAID NIH HHS R56 AI032011NIGMS NIH HHS R01 GM056322
6 · The paper itself

Abstract

unlabelledHaemophilus ducreyi causes chancroid, a sexually transmitted infection. A primary means by which this pathogen causes disease involves eluding phagocytosis; however, the molecular basis for this escape mechanism has been poorly understood. Here, we report that the LspA virulence factors of H. ducreyi inhibit phagocytosis by stimulating the catalytic activity of C-terminal Src kinase (Csk), which itself inhibits Src family protein tyrosine kinases (SFKs) that promote phagocytosis. Inhibitory activity could be localized to a 37-kDa domain (designated YL2) of the 456-kDa LspA1 protein. The YL2 domain impaired ingestion of IgG-opsonized targets and decreased levels of active SFKs when expressed in mammalian cells. YL2 contains tyrosine residues in two EPIYG motifs that are phosphorylated in mammalian cells. These tyrosine residues were essential for YL2-based inhibition of phagocytosis. Csk was identified as the predominant mammalian protein interacting with YL2, and a dominant-negative Csk rescued phagocytosis in the presence of YL2. Purified Csk phosphorylated the tyrosines in the YL2 EPIYG motifs. Phosphorylated YL2 increased Csk catalytic activity, resulting in positive feedback, such that YL2 can be phosphorylated by the same kinase that it activates. Finally, we found that the Helicobacter pylori CagA protein also inhibited phagocytosis in a Csk-dependent manner, raising the possibility that this may be a general mechanism among diverse bacteria. Harnessing Csk to subvert the Fcγ receptor (FcγR)-mediated phagocytic pathway represents a new bacterial mechanism for circumventing a crucial component of the innate immune response and may potentially affect other SFK-involved cellular pathways. IMPORTANCE: Phagocytosis is a critical component of the immune system that enables pathogens to be contained and cleared. A number of bacterial pathogens have developed specific strategies to either physically evade phagocytosis or block the intracellular signaling required for phagocytic activity. Haemophilus ducreyi, a sexually transmitted pathogen, secretes a 4,153-amino-acid (aa) protein (LspA1) that effectively inhibits FcγR-mediated phagocytic activity. In this study, we show that a 294-aa domain within this bacterial protein binds to C-terminal Src kinase (Csk) and stimulates its catalytic activity, resulting in a significant attenuation of Src kinase activity and consequent inhibition of phagocytosis. The ability to inhibit phagocytosis via Csk is not unique to H. ducreyi, because we found that the Helicobacter pylori CagA protein also inhibits phagocytosis in a Csk-dependent manner. Harnessing Csk to subvert the FcγR-mediated phagocytic pathway represents a new bacterial effector mechanism for circumventing the innate immune response.

Indexed as

PhagocytosisAnimalsBacterial ProteinsChancroidCSK Tyrosine-Protein KinaseEnzyme ActivationHaemophilus ducreyiHost-Pathogen InteractionsHumansLectinsProtein Structure, Tertiarysrc-Family KinasesBacterial ProteinsCSK protein, humanCSK Tyrosine-Protein KinaseLectinsLspA1 protein, Haemophilus ducreyisrc-Family Kinases

Identifiers

PMID24902122
PMCPMC4030455
OpenAlexW2160312048

What Socratic holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.